You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.

  1. Development of a novel highly effective influenza vaccine

    SBC: Flugen, Inc.            Topic: NIAID

    DESCRIPTION provided by applicant Seasonal influenza flu virus an NIAID category C priority pathogen causes widespread infection resulting in at least million cases of severe illness and deaths worldwide Young children and elderly or immunocompromised individuals are typically at greater risk of severe illness or death from influenza Newly emerging strains can result ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  2. Development of Peptide Antibiotic Nucleic Acids

    SBC: NUBAD, LLC            Topic: NIAID

    DESCRIPTION provided by applicant One of the challenges of research in infectious diseases is to find ways to use the increasing knowledge of the mechanisms underlying disease transformation and progression to develop novel therapeutic strategies for diseases such as increasing menace of bacterial infections Targeting specific RNA such as rRNA which are involved in proliferation and survival ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  3. New heterocyclic inhibitors of filoviruses

    SBC: MICROBIOTIX, INC.            Topic: H

    DESCRIPTION provided by applicant Ebola and Marburg viruses belong to the family Filoviridae and can cause fatal hemorrhagic fevers characterized by widespread tissue destruction with an incubation period of days Because of the safety concerns these viruses are designated as the biosafety level agents Currently there is no effective vaccine or therapeutic treatment against filoviral i ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  4. New small molecule inhibitors of arenaviruses

    SBC: MICROBIOTIX, INC.            Topic: R

    DESCRIPTION provided by applicant Lassa fever virus LASV and Machupo virus MACV are hemorrhagic fever arenaviruses which are classified as Category A Agents Currently there are no licensed LASV or MACV vaccines and LASV MACV therapy is limited to use of the nucleoside analog ribavirin which is only partially effective and associated with significant side effects The impact of arenavirus ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  5. Light-Weight, Solar Cells with High Specific Power and Conversion Efficiency

    SBC: AGILTRON, INC.            Topic: N14AT003

    Agiltron in collaboration with National Renewable Energy Laboratory (NREL) will develop a new class of high-efficiency and lightweight broadband inverted metamorphic multi-junction (IMM) solar cells for the uninterrupted flight missions of unmanned aerial vehicles (UAVs). The approach is closely coupled with Agiltrons extensive experience in high-transmittance broadband and wide-angle anti-reflect ...

    STTR Phase I 2014 Department of DefenseNavy
  6. Coupled Multi-physics Analysis and Design Optimization of nozzles (COMANDO)

    SBC: INTELLIGENT AUTOMATION, INC.            Topic: N14AT005

    The US Navy faces daunting energy challenges that will further increase in severity, given the ever-increasing global demand for energy, diminishing energy supplies and demand for enhanced environmental stewardship. Navys environment foot print consists of both emissions and noise generated every day around the world. Additionally, noise is an important issue for the Navy due to the adverse effect ...

    STTR Phase I 2014 Department of DefenseNavy
  7. Development of a Safer Lithium-ion (Li-ion) Battery for Naval Aircraft Applications Through Thermal Management Design

    SBC: EIC LABORATORIES, INC.            Topic: N14AT006

    EIC, in collaboration with NREL, proposes to develop safe, large-format aircraft Li-ion batteries where thermal propagation of an overheated cell to neighboring cells or group of cells will be prevented by integrating novel thermal management technologies.

    STTR Phase I 2014 Department of DefenseNavy
  8. Novel, Low-Cost Phased Arrays Manufactured by 3D Printing (1000-295)

    SBC: SI2 TECHNOLOGIES, INC.            Topic: N14AT021

    SI2 Technologies, Inc. (SI2) proposes to develop printed, high-efficiency phased arrays operating at Navy-relevant frequencies. The proposed development effort will include trade studies identifying the best printing technique or combination of techniques to meet the Navys phased array performance goals. The printed array will incorporate both printed radiating elements and an innovative printed p ...

    STTR Phase I 2014 Department of DefenseNavy
  9. Multi-Modal Miniature Integrated Circuit Reporting Overall Status: MICROS

    SBC: Vivonics, Inc.            Topic: N14AT019

    Continuous monitoring of bioelectrical signals can provide valuable insight to subjects stress, fatigue, resilience, and overall health. A rugged, miniaturized, low-power integrated circuit that has the ability to detect a wide variety of signals using noncontact electrodes lends itself to a valuable platform for a wearable system to assess an individuals physical and mental status. We propose suc ...

    STTR Phase I 2014 Department of DefenseNavy
  10. Compact CMOS-Compatible Optical Transceiver

    SBC: Physical Sciences Inc.            Topic: AF14AT13

    ABSTRACT: Close integration of photonic devices with silicon complementary metal-oxide semiconductor (CMOS) electronics can yield significant performance improvements in many applications. The recent development of novel integrated structures in silicon including waveguides, resonators, and photodetectors will enable dramatic reductions in size, weight, and power for components implementing compl ...

    STTR Phase I 2014 Department of DefenseAir Force
US Flag An Official Website of the United States Government